NCT01934036

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

Efficacy and Safety of Obex®, a Nutritional Supplement, in Overweight or Obese Women

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 92 (actual)
• Sponsor: Catalysis SL · Industry
• Sex: Female
• Age: 35 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to evaluate the effects of a dietary supplement (Obex®) on anthropometric and physiological variables in Spanish women between 35 and 60 years who are overweight or obese.

Detailed description

The nutritional supplement consists of natural plant extracts such as Caralluma fimbriata, Phaseolus vulgaris, Acai Berry and other antiobesity agents: ornithine, carnitine fumarate, essential fatty acids and certain amino acids, vitamins and minerals.

Conditions

• Obesity
• Overweight

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Obex	After concluded the two months of treatment, patients will be follow-up during three months without consumption of Obex.
DRUG	Placebo	After concluded the two months of treatment, patients will be follow-up during three months without consumption of the placebo.

Timeline

• Start date: 2013-08-01
• Primary completion: 2014-02-01
• Completion: 2014-02-01
• First posted: 2013-09-04
• Last updated: 2014-02-25

Locations

1 site across 1 country: Spain